These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7799389)

  • 1. Guidelines for testing slow acting drugs in osteoarthritis.
    Lequesne M; Brandt K; Bellamy N; Moskowitz R; Menkes CJ; Pelletier JP; Altman R
    J Rheumatol Suppl; 1994 Sep; 41():65-71; discussion 72-3. PubMed ID: 7799389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodology of clinical trials in hand osteoarthritis. Issues and proposals.
    Maheu E; Dreiser RL; Lequesne M
    Rev Rhum Engl Ed; 1995 Jun; 62(6 Suppl 1):55S-62S. PubMed ID: 7583183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores.
    Wu CW; Morrell MR; Heinze E; Concoff AL; Wollaston SJ; Arnold EL; Singh R; Charles C; Skovrun ML; FitzGerald JD; Moreland LW; Kalunian KC
    Semin Arthritis Rheum; 2005 Dec; 35(3):197-201. PubMed ID: 16325660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraarticular treatment of osteoarthritis and guidelines to its assessment.
    Menkes CJ
    J Rheumatol Suppl; 1994 Sep; 41():74-6. PubMed ID: 7799390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between NSAID use and osteoarthritis (OA) severity in patients with hip and knee OA: results of a case control study of NSAID use comparing those requiring hip and knee replacements to those in whom surgery was not recommended.
    Pope JE; McCrea K; Stevens A; Ouimet JM
    Med Sci Monit; 2008 Dec; 14(12):CR604-10. PubMed ID: 19043367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
    Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
    J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroprotective drugs in degenerative joint diseases.
    Verbruggen G
    Rheumatology (Oxford); 2006 Feb; 45(2):129-38. PubMed ID: 16278282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Do 'chondroprotective agents' agents exist in osteoarthritis? Required proof].
    Lequesne M; Cadet C
    Therapie; 1998; 53(1):7-16. PubMed ID: 9773094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
    Detora LM; Krupa D; Bolognese J; Sperling RS; Ehrich EW
    J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging can accurately assess the long-term progression of knee structural changes in experimental dog osteoarthritis.
    Boileau C; Martel-Pelletier J; Abram F; Raynauld JP; Troncy E; D'Anjou MA; Moreau M; Pelletier JP
    Ann Rheum Dis; 2008 Jul; 67(7):926-32. PubMed ID: 17962236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical correlates of articular cartilage defects in symptomatic knee osteoarthritis: a prospective study.
    Wluka AE; Ding C; Jones G; Cicuttini FM
    Rheumatology (Oxford); 2005 Oct; 44(10):1311-6. PubMed ID: 16030084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroprotective/structure-modifying drugs: a neverending story.
    Henrotin Y
    Reumatismo; 2006; 58 Spec No.1():15-6. PubMed ID: 23631055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Slow-acting anti-rheumatic agents: recent developments].
    Van Linthoudt D; Gerster JC
    Rev Med Suisse Romande; 2004 Sep; 124(9):565-7. PubMed ID: 15552752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoarthritis.
    Mahajan A; Verma S; Tandon V
    J Assoc Physicians India; 2005 Jul; 53():634-41. PubMed ID: 16190135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis.
    Hunter DJ; Zhang YQ; Niu JB; Tu X; Amin S; Clancy M; Guermazi A; Grigorian M; Gale D; Felson DT
    Arthritis Rheum; 2006 Mar; 54(3):795-801. PubMed ID: 16508930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with hip cartilage volume measured by magnetic resonance imaging: the Tasmanian Older Adult Cohort Study.
    Zhai G; Cicuttini F; Srikanth V; Cooley H; Ding C; Jones G
    Arthritis Rheum; 2005 Apr; 52(4):1069-76. PubMed ID: 15818695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.
    Gossec L; Hawker G; Davis AM; Maillefert JF; Lohmander LS; Altman R; Cibere J; Conaghan PG; Hochberg MC; Jordan JM; Katz JN; March L; Mahomed N; Pavelka K; Roos EM; Suarez-Almazor ME; Zanoli G; Dougados M
    J Rheumatol; 2007 Jun; 34(6):1432-5. PubMed ID: 17552070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.